Tango Therapeutics, Inc 10-K for FY2025
Tango Therapeutics, Inc. (TNGX)
10-K
2026-03-05
For: 2025-12-31
View Original
Added on
April 08, 2026
About this 10-K
Tango Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $62.38M
- up 48.3% from $42.07M a year earlier
- Net loss
- $101.59M
- compared with a net loss of $130.3M a year earlier
- Diluted EPS
- -$0.87
- compared with -$1.19 a year earlier